InternationalUSRemember you can easily switch between MIP US and MIP International at any time

China’s generics push a bitter pill for pharma to swallow

Karry Lai, Hong Kong

Innovator drug companies express concern over the large number of generics being approved before patents expire in China

DrugsA troubling trend of “ruleless competitors” is worrying pharmaceutical companies, according to heads of IP at multinational businesses in China.  

In 2019 alone, the National Medical Products Administration (NMPA) has approved 10 generics in the course of 10...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Most read articles

Latest Country Updates